| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6198 | 2005 |
| A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ... New England Journal of Medicine 350 (12), 1200-1210, 2004 | 3329 | 2004 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2149 | 1998 |
| Phase 2 of CATALISE: A multinational and multidisciplinary Delphi consensus study of problems with language development: Terminology DVM Bishop, MJ Snowling, PA Thompson, T Greenhalgh, ... Journal of child psychology and psychiatry 58 (10), 1068-1080, 2017 | 1348 | 2017 |
| Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) AM Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ... Journal of Clinical Oncology 36 (20), 2017-2023, 2018 | 1334 | 2018 |
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial JP Neoptolemos, JA Dunn, DD Stocken, J Almond, K Link, H Beger, ... The Lancet 358 (9293), 1576-1585, 2001 | 1334 | 2001 |
| Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer JA Witjes, T Lebret, EM Compérat, NC Cowan, M De Santis, HM Bruins, ... European urology 71 (3), 462-475, 2017 | 1256 | 2017 |
| SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. 2. O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ... Lancet 339 (8785), 71-85, 1992 | 1084 | 1992 |
| Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ... Journal of Clinical Oncology 27 (33), 5513-5518, 2009 | 978 | 2009 |
| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 932 | 2019 |
| Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of oncology 25 (8), 1536-1543, 2014 | 824 | 2014 |
| Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial JP Neoptolemos, DD Stocken, JA Dunn, J Almond, HG Beger, P Pederzoli, ... Annals of surgery 234 (6), 758-768, 2001 | 727 | 2001 |
| Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial HER Ford, A Marshall, JA Bridgewater, T Janowitz, FY Coxon, J Wadsley, ... The lancet oncology 15 (1), 78-86, 2014 | 680 | 2014 |
| PET-CT surveillance versus neck dissection in advanced head and neck cancer H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ... New England Journal of Medicine 374 (15), 1444-1454, 2016 | 628 | 2016 |
| Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical … BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, G Morgan, ... Journal of clinical oncology 23 (36), 9219-9226, 2005 | 597 | 2005 |
| The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up MT Hallissey, JA Dunn, LC Ward, WH Allum, BSC Group The Lancet 343 (8909), 1309-1312, 1994 | 441 | 1994 |
| Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. M Pasquali, J Vela, R Kyle, T Leong, E Fritz, S Suciu, IP Palva, T Oivanen, ... Journal of Clinical Oncology 16 (12), 3832-3842, 1998 | 435 | 1998 |
| A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma McCloskey, MacLennan, Drayson, Chapman, Kanis, ... British journal of haematology 100 (2), 317-325, 1998 | 405 | 1998 |
| Cigarette Smoking and pancreas cancer: A case—Control study based on direct interviews DT Silverman, JA Dunn, RN Hoover, M Schiffiman, KD Lillemoe, ... JNCI: Journal of the National Cancer Institute 86 (20), 1510-1516, 1994 | 395 | 1994 |
| PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ... Annals of Oncology 26 (7), 1488-1493, 2015 | 324 | 2015 |
